Irina Kumar
Physician Assistant · South Gate, CANPI 1851414247
Payments from drug & device makers
Across 246 payments — averaging $26.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$885
- AstraZeneca$544
- Pfizer$353
- Dexcom, Inc.$349
- Lilly USA, LLC$345
- plus $2K from 23 others
What the payments were for
- Speaking & faculty fees$1,37521%
- Food & beverage$5,13779%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $1,671 |
| Novo Nordisk | 58 | $885 |
| AstraZeneca | 19 | $544 |
| Pfizer | 15 | $353 |
| Dexcom, Inc. | 10 | $349 |
| Lilly USA, LLC | 16 | $345 |
| Boehringer Ingelheim | 13 | $345 |
| Bayer | 10 | $336 |
| Johnson & Johnson | 10 | $269 |
| Sanofi-aventis U.S. LLC | 12 | $232 |
| Amgen(2 entities) | 10 | $190 |
| GSK | 10 | $182 |
| Shield Therapeutics Inc | 7 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $154 |
| Merck | 6 | $101 |
| Exact Sciences | 3 | $85 |
| Amarin Pharma, Inc. | 2 | $47 |
| Sanofi Pasteur Inc. | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Phadia US Inc. | 2 | $31 |
| Sage Therapeutics, LLC | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Seqirus USA Inc | 1 | $25 |
| Mannkind Corporation | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Cranial Technologies, Inc | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Evofem Biosciences, Inc. | 2 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$1,375
- DEXCOM G6 TRANSMITTER$167
- Kerendia$126
- BREZTRI$123
How this compares
$6,524 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 128 | $164,421 |
| TrulicityDulaglutide | 62 | $93,931 |
| JardianceEmpagliflozin | 38 | $42,456 |
| JanumetSitagliptin Phos/Metformin Hcl | 29 | $35,297 |
| SynjardyEmpagliflozin/Metformin Hcl | 21 | $34,906 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $29,846 |
| JanuviaSitagliptin Phosphate | 19 | $28,551 |
| FarxigaDapagliflozin Propanediol | 29 | $26,464 |
| LinzessLinaclotide | 26 | $18,085 |
| ProliaDenosumab | 11 | $18,025 |
| Xigduo XrDapaglifloz Propaned/Metformin | 18 | $17,812 |
| XareltoRivaroxaban | 18 | $17,729 |
| TrintellixVortioxetine Hydrobromide | 14 | $13,951 |
| EliquisApixaban | 15 | $11,777 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 62 | $9,345 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $885 | $164,421128 claims |
| Lilly USA, LLCTrulicity | $345 | $93,93162 claims |
| Boehringer IngelheimJardiance, Synjardy | $345 | $77,36259 claims |
| MerckJanumet, Januvia | $101 | $63,84848 claims |
| AstraZenecaFarxiga | $544 | $26,46429 claims |
| AbbVieLinzess | $1,671 | $18,08526 claims |
| AmgenProlia | $190 | $18,02511 claims |
| Johnson & JohnsonXarelto | $269 | $17,72918 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $154 | $13,95114 claims |
| PfizerEliquis | $353 | $11,77715 claims |
| GSKTrelegy Ellipta | $182 | $6,54311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in South Gate
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.